Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Authors | |
---|---|
Year of publication | 2024 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |